Results 41 to 50 of about 54,678 (274)
LINC01537 Regulates Malignant Phenotypes and Predicts Prognosis in Breast Cancer, and Its Bioinformatics Analysis. [PDF]
LINC01537 is upregulated in breast cancer, predicting poor prognosis; it acts as a ceRNA sponging miR‐138‐5p to upregulate EZH2, promoting breast cancer progression via this axis. ABSTRACT Breast cancer is a highly heterogeneous malignancy and constitutes one of the leading health threats to women globally.
Guo Y, Shi L.
europepmc +2 more sources
Targeting the EZH2–EED Interaction Inhibits EZH2 Activity [PDF]
Abstract A peptide that prevents EZH2 from binding EED inhibits growth of EZH2-dependent cancer cells.
openaire +1 more source
EZH2 in normal and malignant hematopoiesis [PDF]
The histone methyltransferase Enhancer of Zeste Homologue 2 (EZH2), a component of the polycomb group complex, is vital for stem cell development, including hematopoiesis. Its primary function, to deposit the histone mark H3K27me3, promotes transcriptional repression. The activity of EZH2 influences cell fate regulation, namely the balance between self-
K, Lund, P D, Adams, M, Copland
openaire +2 more sources
EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma
Background Overexpressed EZH2 is oncogenically involved in the pathogenesis of different cancerous contexts including extranodal natural killer/T cell lymphoma (ENKTL). However, the underlying mechanisms of EZH2 upregulation have not been fully clarified
Boheng Li +10 more
doaj +1 more source
Evaluation of EZH2 and ERRα in colorectal carcinoma: an immunohistochemical study
The combined immunohistochemical evaluation of EZH2 (enhancer of zeste homolog 2) and ERRα (estrogen-related receptor α), in relation to clinicopathological prognostic factors and patients’ outcome, has not been performed yet in colorectal carcinoma (CRC)
Hoda Abou Gabal +4 more
doaj +1 more source
Epizyme researchers have clarified how mutations in the histone methyltransferase EZH2 lead to increased enzyme activity. With small molecule inhibitors in hand, the biotech now will put EZH2-targeted therapy to the test in mouse models of lymphomas and other EZH2-associated cancers.
openaire +1 more source
Dynamics and epigenetic control of PcG proteins during skeletal muscle cell differentiation [PDF]
During skeletal muscle differentiation, signal dependent switches in cell differentiation programs require global rearrangements in repression and activation of lineage specific genes, hence the importance of unravelling epigenetic mechanisms that ...
Prezioso, Carolina
core +1 more source
Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer [PDF]
Enhancer of zeste homolog2 (EZH2) is the histone lysine N-methyltransferase component of the Polycomb repressive complex 2 (PRC2), which in conjunction with embryonic ectoderm development (EED) and suppressor of zeste 12 homolog (SUZ12), regulates cell ...
Neff, Tobias +6 more
core +1 more source
The methyltransferase EZH2 plays an important role in regulating chromatin conformation and gene transcription. Phosphorylation of EZH2 at S21 by AKT kinase suppresses its function.
Lan Zhang +24 more
doaj +1 more source
Easy Stress Relief by EZH2 [PDF]
While we are beginning to appreciate the cellular roles played by long noncoding RNAs, the function of transcripts emerging from repetitive genomic regions remains enigmatic. In this issue, Zovoilis et al. report that the polycomb protein EZH2, upon heat shock, facilitates transcription of stress-responsive genes by inducing the degradation of the ...
Supriya G, Prasanth +1 more
openaire +2 more sources

